From Elsevier Business Intelligence
Including company and deal data plus articles from publications like IN VIVO, Start-Up, The RPM Report, and Medtech Insight.

H. Lundbeck AS

www.lundbeck.com

Most Recent Related Deals

Lundbeck pays $147mm for tetrabenazine originator LifeHealth, 7/2009
Lundbeck acquires nerve cell specialist NeuronIcon, 7/2009
Forest, Lundbeck settle patent case, grant Caraco rights, 7/2009
Lundbeck buys spec pharma Ovation for $600mm plus earn-outs, 2/2009
Ovation takes US rights to Xenazine from Prestwick, 9/2008
Ovation gets US rights to GTC's ATryn, 6/2008
Lundbeck to sell Myriad's Flurizan in Europe;terminated, 5/2008
Lundbeck takes on siramesine from TopoTarget, 10/2007
Takeda and H. Lundbeck in $385mm depression deal, 9/2007
Lundbeck gets European rights to Neurim's Circadin, 9/2007

Most Recent Related Articles

Click an article to see a free preview (15 of 82).

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q3 2009, Start-Up 11/2009
Dealmaking When Pharma's the Only Game in Town, Start-Up 9/2009
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q2 2009, Start-Up 9/2009
Best of the Blog: IN VIVO, April 2009, Start-Up 5/2009
Best of the Blog: IN VIVO February 2009, Start-Up 3/2009
The Billion Dollar REMS: Xenazine and the Value of Facing Regulatory Realities, Medtech Insight 2/2009
GTCR Dips into Devices with Devicor, In Vivo 2/2009
Best of the Blog: IN VIVO, September 2008, Start-Up 10/2008
Best of the Blog: IN VIVO, September 2008, IN VIVO 10/2008
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q2 2008, Start-Up 9/2008
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q2 2008, IN VIVO 9/2008
Deals in Depth: May 2008, IN VIVO 7/2008
GSK/Actelion: Phase III Value Is in the Eye of the Beholder, Start-Up 7/2008
GSK/Actelion: Phase III Value Is in the Eye of the Beholder, IN VIVO 7/2008
New Alzheimer's Disease Target and a Potentially Broad Drug Discvoery Approach, Start-Up 6/2008

See all 82 articles about this company

Copyright © 2009 Elsevier Inc. All rights reserved. Elsevier Business Intelligence, www.ElsevierBI.com.
Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com.